SHIFT BIOSCIENCE LIMITED
Company number 10793871 · Active · Cambridge CB1 2LA
SHIFT BIOSCIENCE LIMITED is an active private limited company (company number 10793871) incorporated on 30 May 2017, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £4.26m and cash of £1.28m, with 18 employees on average. Net assets fell 51% on the prior period (£8.74m).
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Key dates
- Incorporated
- 30 May 2017
- Next accounts due
- 30 March 2027 — in 161 days
- Confirmation statement due
- 13 June 2027 — in 236 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Small (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 June 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £4.26m | £1.28m | — | £447k | — | — | 18 |
| 30 June 2024 | £8.74m | £8.28m | — | £364k | — | — | 11 |
- Current ratio
- 10.09 — comfortable
- Cash per employee
- £71k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 72/100 (grade B)
- +10 Positive net assets — Net assets £4,257,099 at 2025-06-30
- -8 Net assets falling — -51.3% vs prior period
- +8 Comfortable liquidity — Current ratio 10.09
- +4 Cash reserves — Cash £1,283,585
- +8 Established — Incorporated 2017-05-30 (9 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Dr Daniel Jeremy Ives — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 30 May 2017
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Cambridge
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- SOLASCURE LIMITED — Cambridge, inc. Jun 2017
- CRITICAL PRESSURE LIMITED — Cambridge, inc. Jun 2017
- NERRE THERAPEUTICS HOLDINGS LIMITED — Cambridge, inc. May 2017
- RDP LIFE SCIENCES LIMITED — Cambridge, inc. Apr 2017
- MURSLA LIMITED — Cambridge, inc. Apr 2017
- OXCITAS LIMITED — Cambridge, inc. Jul 2017
Reminders for SHIFT BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.